首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4254篇
  免费   353篇
  国内免费   28篇
耳鼻咽喉   3篇
儿科学   57篇
妇产科学   37篇
基础医学   572篇
口腔科学   6篇
临床医学   480篇
内科学   1087篇
皮肤病学   12篇
神经病学   53篇
特种医学   33篇
外科学   94篇
综合类   152篇
现状与发展   2篇
预防医学   1864篇
眼科学   9篇
药学   124篇
中国医学   3篇
肿瘤学   47篇
  2024年   12篇
  2023年   370篇
  2022年   263篇
  2021年   282篇
  2020年   564篇
  2019年   362篇
  2018年   308篇
  2017年   275篇
  2016年   284篇
  2015年   349篇
  2014年   306篇
  2013年   209篇
  2012年   146篇
  2011年   113篇
  2010年   173篇
  2009年   155篇
  2008年   50篇
  2007年   58篇
  2006年   39篇
  2005年   32篇
  2004年   26篇
  2003年   32篇
  2002年   35篇
  2001年   25篇
  2000年   16篇
  1999年   23篇
  1998年   20篇
  1997年   19篇
  1996年   30篇
  1995年   9篇
  1994年   12篇
  1993年   3篇
  1992年   5篇
  1991年   2篇
  1990年   2篇
  1989年   1篇
  1988年   9篇
  1987年   8篇
  1986年   7篇
  1985年   1篇
排序方式: 共有4635条查询结果,搜索用时 281 毫秒
121.
122.
123.
A patient was diagnosed with discitis and sacroiliitis due to Mycobacterium xenopi. He had a history of percutaneous nucleotomy performed 15 years earlier (in 1992) at the Clinique du Sport, Paris, France, during an outbreak of nosocomial M. xenopi infection at that institution. In 1997, magnetic resonance imaging performed as part of the routine follow-up program for patients who had surgery at the Clinique du Sport during the outbreak was not interpreted as indicating discitis; this assessment was confirmed by our review of the images. Bone and joint infections due to atypical mycobacteria are rare and can develop very slowly. To our knowledge, this is the first reported case of M. xenopi discitis with secondary extension to the sacroiliac joint in an immunocompetent patient.  相似文献   
124.
125.
《Vaccine》2018,36(6):779-787
In Italy, in 2016, we conducted a cross-sectional survey to estimate vaccine hesitancy and investigate its determinants among parents of children aged 16–36 months.Data on parental attitudes and beliefs about vaccinations were collected through a questionnaire administered online or self-administered at pediatricians’ offices and nurseries. Parents were classified as pro-vaccine, vaccine-hesitant or anti-vaccine, according to self-reported tetanus and measles vaccination status of their child. Multivariable logistic regression was used to investigate factors associated with hesitancy.A total of 3130 questionnaires were analysed: 83.7% of parents were pro-vaccine, 15.6% vaccine-hesitant and 0.7% anti-vaccine. Safety concerns are the main reported reason for refusing (38.1%) or interrupting (42.4%) vaccination. Anti-vaccine and hesitant parents are significantly more afraid than pro-vaccine parents of short-term (85.7 and 79.7% vs 60.4%) and long-term (95.2 and 72.3% vs 43.7%) vaccine adverse reactions. Most pro-vaccine and hesitant parents agree about the benefits of vaccinations. Family pediatricians are considered a reliable source of information by most pro-vaccine and hesitant parents (96.9 and 83.3% respectively), against 45% of anti-vaccine parents. The main factors associated with hesitancy were found to be: not having received from a paediatrician a recommendation to fully vaccinate their child [adjusted odds ratio (AOR): 3.21, 95% CI: 2.14–4.79], having received discordant opinions on vaccinations (AOR: 1.64, 95% CI: 1.11–2.43), having met parents of children who experienced serious adverse reactions (AOR: 1.49, 95% CI: 1.03–2.15), and mainly using non-traditional medical treatments (AOR: 2.05, 95% CI: 1.31–3.19).Vaccine safety is perceived as a concern by all parents, although more so by hesitant and anti-vaccine parents. Similarly to pro-vaccine parents, hesitant parents consider vaccination an important prevention tool and trust their family pediatricians, suggesting that they could benefit from appropriate communication interventions. Training health professionals and providing homogenous information about vaccinations, in line with national recommendations, are crucial for responding to their concerns.  相似文献   
126.
127.
128.
129.
130.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号